Another review demonstrates that the medication fenofibrate may lessen the danger of cardiovascular occasions in patients with sort 2 diabetes who have large amounts of triglycerides and low levels of "good" cholesterol, regardless of being treated with statins.
The review, supported by the National Heart, Lung, and Blood Institute (NHLBI), shows up in the December 28 issue of JAMA Cardiology.
Fenofibrate is principally used to lessen lifted levels of triglycerides, or fat, in the blood. Be that as it may, the scientists needed to know whether the medication, when consolidated with statin treatment, could likewise lessen the danger of coronary illness in individuals with sort 2 diabetes.
Individuals with sort 2 diabetes are at high danger of cardiovascular-related occasions, for example, heart assaults, stroke, and even demise, regularly in light of the fact that their levels of triglycerides are so high, and their high-thickness lipoprotein (HDL) cholesterol levels are low.
To answer their question, the specialists took after 4,640 members from the NHLBI-subsidized Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Study for a long time after the finish of the trial in 2009.
The discoveries recommend that fenofibrate treatment might be valuable in the way the specialists trusted: by diminishing cardiovascular occasions in patients with sort 2 diabetes who take statins yet at the same time have particularly high triglycerides levels and low HDL cholesterol levels.
Be that as it may, a randomized review is expected to affirm these discoveries, as indicated by the creators.
Take after Knowridge Science Report on Facebook, Twitter and Flipboard.
News source: NIH/National Heart, Lung and Blood Institute. The substance is altered for length and style purposes.
Figure legend: This Knowridge.com picture is for illustrative purposes as it were.
The review, supported by the National Heart, Lung, and Blood Institute (NHLBI), shows up in the December 28 issue of JAMA Cardiology.
Fenofibrate is principally used to lessen lifted levels of triglycerides, or fat, in the blood. Be that as it may, the scientists needed to know whether the medication, when consolidated with statin treatment, could likewise lessen the danger of coronary illness in individuals with sort 2 diabetes.
Individuals with sort 2 diabetes are at high danger of cardiovascular-related occasions, for example, heart assaults, stroke, and even demise, regularly in light of the fact that their levels of triglycerides are so high, and their high-thickness lipoprotein (HDL) cholesterol levels are low.
To answer their question, the specialists took after 4,640 members from the NHLBI-subsidized Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Study for a long time after the finish of the trial in 2009.
The discoveries recommend that fenofibrate treatment might be valuable in the way the specialists trusted: by diminishing cardiovascular occasions in patients with sort 2 diabetes who take statins yet at the same time have particularly high triglycerides levels and low HDL cholesterol levels.
Be that as it may, a randomized review is expected to affirm these discoveries, as indicated by the creators.
Take after Knowridge Science Report on Facebook, Twitter and Flipboard.
News source: NIH/National Heart, Lung and Blood Institute. The substance is altered for length and style purposes.
Figure legend: This Knowridge.com picture is for illustrative purposes as it were.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.